drugset / Trial / NCT01321827
Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Phase 2/3
Completed
100 enrolled
Post Graduate Institute of Medical Education and Research, Chandigarh
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of itraconazole monotherapy in patients with ABPA.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-03
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | Oral |
| Subject | Prednisolone | Other / unclassified | 0.125 mg/kg | Oral |